BNT211, BNT211, BNT211, BNT211
BNT211-01
Phase 1 small_molecule active
Quick answer
BNT211, BNT211, BNT211, BNT211 for Solid Tumors is a Phase 1 program (small_molecule) at BioNTech Manufacturing GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- BioNTech Manufacturing GmbH
- Indication
- Solid Tumors
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active